Point72 Asia (Singapore) Pte. Ltd. Alector, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Alector, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 12,045 shares of ALEC stock, worth $13,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,045Holding current value
$13,369% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
148Shares Held
55.2MCall Options Held
56.4KPut Options Held
23.2K-
Ra Capital Management, L.P. Boston, MA9.7MShares$10.8 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$10.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$6.72 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$2.18 Million0.0% of portfolio
-
State Street Corp Boston, MA1.64MShares$1.82 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $91.6M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...